Published in Oncology (Williston Park) on July 01, 2010
Outcomes assessment in men undergoing open retropubic radical prostatectomy, laparoscopic radical prostatectomy, and robotic-assisted radical prostatectomy. World J Urol (2011) 0.84
Deciding which patients to treat with salvage radiotherapy after prostatectomy. Oncology (Williston Park) (2010) 0.75
Who, when, where, and how: salvage prostate cancer with radiotherapy. Oncology (Williston Park) (2010) 0.75
The pattern of polymorphism in Arabidopsis thaliana. PLoS Biol (2005) 10.13
An Arabidopsis example of association mapping in structured samples. PLoS Genet (2006) 7.03
Genome-wide association mapping in Arabidopsis identifies previously known flowering time and pathogen resistance genes. PLoS Genet (2005) 4.25
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol (2011) 4.11
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol (2012) 3.34
Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol (2012) 3.07
Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol (2004) 2.96
Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol (2010) 2.90
The relationship between clinical benefit and receipt of curative therapy for prostate cancer. Arch Intern Med (2012) 2.48
The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care (2011) 2.38
The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med (2009) 2.32
Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system. Oncology (Williston Park) (2012) 2.29
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg (2012) 2.28
Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology (2013) 2.16
Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care (2014) 2.14
A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol (2009) 2.10
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer. Cancer (2013) 2.10
Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study. Urology (2013) 2.08
Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A (2002) 1.93
Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. Ann Surg (2007) 1.74
Population based cancer registry analysis of primary tracheal carcinoma. Am J Clin Oncol (2011) 1.71
A retrospective review of 1349 cases of sebaceous carcinoma. Cancer (2009) 1.70
The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. Am J Surg (2008) 1.66
Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncol Rep (2011) 1.66
Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy. Int J Radiat Oncol Biol Phys (2011) 1.63
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.59
Plasmon-enhanced ultraviolet photoluminescence from hybrid structures of graphene/ZnO films. Phys Rev Lett (2010) 1.56
Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology (2010) 1.55
Geographical information systems: applications and limitations in oncology research. Oncology (Williston Park) (2011) 1.52
Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care. Med Care (2014) 1.50
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker. Clin Cancer Res (2004) 1.42
Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer. Int J Radiat Oncol Biol Phys (2013) 1.40
Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clin Cancer Res (2011) 1.39
In regard to "Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series." (Int J Radiat Oncol Biol Phys 2012;83:624-629). Int J Radiat Oncol Biol Phys (2012) 1.37
Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood (2010) 1.34
Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol (2012) 1.34
Analysis of pacemaker activity in the human stomach. J Physiol (2011) 1.28
MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas. Mod Pathol (2013) 1.25
Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys (2012) 1.25
Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer. Ann Surg Oncol (2009) 1.23
Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. Radiat Oncol (2012) 1.21
Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer (2011) 1.19
Recurrence after curative resection of early gastric cancer. Ann Surg Oncol (2009) 1.19
Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009. Cancer (2014) 1.18
Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy. Clin Cancer Res (2007) 1.16
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol (2011) 1.16
The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population. J Urol (2011) 1.16
Borrmann type IV: an independent prognostic factor for survival in gastric cancer. J Gastrointest Surg (2008) 1.14
Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation. Int J Radiat Oncol Biol Phys (2011) 1.13
Glomus tumor of the stomach: a clinicopathologic analysis of 10 cases and review of the literature. Gut Liver (2012) 1.12
Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg (2012) 1.11
Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat. Health Aff (Millwood) (2012) 1.09
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol (2009) 1.08
Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature. Clin Cancer Res (2009) 1.08
Health-related quality of life among disease-free stomach cancer survivors in Korea. Qual Life Res (2006) 1.06
Laparoscopic "Dome-down" cholecystectomy with the LCS-5 Harmonic scalpel. JSLS (2005) 1.06
Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy. Hum Gene Ther (2006) 1.05
Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Curr Probl Cancer (2012) 1.04
Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. Int J Radiat Oncol Biol Phys (2009) 1.03
Nutritional risk index as a predictor of postoperative wound complications after gastrectomy. World J Gastroenterol (2012) 1.03
Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008. Int J Radiat Oncol Biol Phys (2012) 1.02
Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea. Asia Pac J Clin Oncol (2011) 1.02
Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM. Arch Surg (2009) 1.02
Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Ann Surg (2008) 1.01
Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases. Am J Surg Pathol (2010) 1.01
The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications. Int J Radiat Oncol Biol Phys (2012) 1.00
Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas. Mod Pathol (2012) 1.00
Gastric cancer staging at isotropic MDCT including coronal and sagittal MPR images: endoscopically diagnosed early vs. advanced gastric cancer. Abdom Imaging (2009) 0.99
Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer. Int J Cancer (2010) 0.98
Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells. Cytokine (2008) 0.97
Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy. Clin Cancer Res (2008) 0.97
Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma. APMIS (2009) 0.97
Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor. Hepatogastroenterology (2004) 0.97
A new suggestion for the radiation target volume after a subtotal gastrectomy in patients with stomach cancer. Int J Radiat Oncol Biol Phys (2008) 0.96
The cost implications of prostate cancer screening in the Medicare population. Cancer (2013) 0.95
The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy. J Surg Oncol (2011) 0.95
Comparison of four immunohistochemical tests and FISH for measuring HER2 expression in gastric carcinomas. Pathology (2012) 0.95
Mucinous gastric cancer presents with more advanced tumor stage and weaker β-catenin expression than nonmucinous cancer. Ann Surg Oncol (2010) 0.95
Surgical outcome of synchronous second primary cancer in patients with gastric cancer. Yonsei Med J (2007) 0.95
Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer (2013) 0.94
A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clin Cancer Res (2013) 0.93
3D meshless prostate segmentation and registration in image guided radiotherapy. Med Image Comput Comput Assist Interv (2009) 0.93
HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy. Int J Cancer (2014) 0.93
Laparoscopy-assisted distal gastrectomy in a patient with early gastric cancer and polysplenia. Surg Laparosc Endosc Percutan Tech (2012) 0.93
Age, race, sex, stage, and incidence of cutaneous lymphoma. Clin Lymphoma Myeloma Leuk (2012) 0.92
A Risk-prediction Model Based on Lymph-node Metastasis for Incorporation Into a Treatment Algorithm for Signet Ring Cell-type Intramucosal Gastric Cancer. Ann Surg (2016) 0.92
Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma. Br J Ophthalmol (2009) 0.92
Regional differences of the effects of acetylcholine in the human gastric circular muscle. Am J Physiol Gastrointest Liver Physiol (2010) 0.92
The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.92
Concurrent segmentation of the prostate on MRI and CT via linked statistical shape models for radiotherapy planning. Med Phys (2012) 0.91
Limitations and biases of the Surveillance, Epidemiology, and End Results database. Curr Probl Cancer (2012) 0.91
Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression. J Surg Res (2008) 0.91
Glycomimetic ligands for the human asialoglycoprotein receptor. J Am Chem Soc (2012) 0.91
Geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys (2011) 0.91
Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.91
Melanoma brain metastases: is it time to reassess the bias? Curr Probl Cancer (2011) 0.90